Abstract

Oligonucleotide drugs represent an emerging area in the pharmaceutical industry. Solid-phase synthesis generates many structurally closely related impurities, making efficient separation systems for purification and analysis a key challenge during pharmaceutical drug development. To increase the fundamental understanding of the important preparative separation step, mass-overloaded injections of a fully phosphorothioated 16mer, i.e., deoxythymidine oligonucleotide, were performed on a C18 and a phenyl column. The narrowest elution profiles were obtained using the phenyl column, and the 16mer could be collected with high purity and yield on both columns. The most likely contribution to the successful purification was the quantifiable displacement of the early-eluting shortmers on both columns. In addition, the phenyl column displayed better separation of later-eluting impurities, such as the 17mer impurity. The mass-overloaded injections resulted in classical Langmuirian elution profiles on all columns, provided the concentration of the ion-pairing reagent in the eluent was sufficiently high. Two additional column chemistries, C4 and C8, were also investigated in terms of their selectivity and elution profile characteristics for the separation of 5–20mers fully phosphorothioated deoxythymidine oligonucleotides. When using triethylamine as ion-pairing reagent to separate phosphorothioated oligonucleotides, we observed peak broadening caused by the partial separation of diastereomers, predominantly seen on the C4 and C18 columns. When using the ion-pair reagent tributylamine, to suppress diastereomer separation, the greatest selectivity was found using the phenyl column followed by C18. The present results will be useful when designing and optimizing efficient preparative separations of synthetic oligonucleotides.

Highlights

  • Therapeutic oligonucleotides (ONs) represent a recent breakthrough in the pharmaceutical industry [1,2,3]

  • In a previous study [20] of PSmodified ONs, we found that selecting the ion-pair reagent in the eluent was crucial for the diastereomer selectivity and the use of trimethylammonium acetate followed by triethylammonium acetate resulted in the best selectivity

  • The retention behavior of deoxythymidine ONs was evaluated using ion-pair Reversed-phase liquid chromatography (RPLC) with two different ion-pair reagents and four different stationary phases

Read more

Summary

Introduction

Therapeutic oligonucleotides (ONs) represent a recent breakthrough in the pharmaceutical industry [1,2,3]. Much research has been focused on developing chromatographic methods to analyze phosphorothioate (PS)-modified ONs, which was recently summarized in a comprehensive review, including discussion about column chemistry and ion-pairing reagents [7]. The homomeric oligonucleotides used in this study represents realistic key model solutes towards reaching a deeper knowledge of separation mechanisms for therapeutic ASOs. The research methodology was to use the knowledge achieved in a recent fundamental study [20] for developing improved ion-pair liquid chromatographic phase systems for analytical and preparative separations of longer ONs (as models for ASOs). In the analytical part of the study, the peak broadening of PS-modified oligonucleotides caused by partial diastereomer separation was investigated on different columns using triethyl- or tributylammonium acetate ion-pairing reagents. Quantitative information about the displacement effects of shortmers was obtained

Material and methods
C8 C18 Phenyl BEH C18
Conclusions
Compliance with ethical standards
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call